Aims to streamline approval for over-the-counter medicines.
This bill would make it simpler for drug companies to get new over-the-counter (OTC) medicines reviewed by the government. It would require the Department of Health and Human Services to use the least burdensome ways to approve these drugs.
Today, the government does not explicitly have to use the 'least burdensome' approach when reviewing over-the-counter drugs. It is also not required to hold specific meetings to guide drug companies on what evidence they need. If this bill becomes law, the Department of Health and Human Services would be directed to use the simplest appropriate methods for reviews. It would also be required to meet with drug companies to provide clear recommendations and document those discussions.
HR 6868 · 119th Congress · December 18, 2025 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
4 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.